Clinical Trials Insight: 700027714
Phase of Trial: Phase II
Latest Information Update: 17 Jun 2008
At a glance
- Drugs Bismaltolatooxovanadium (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics; Therapeutic Use
- Sponsors Akesis Pharmaceuticals
- 17 Jun 2008 Preliminary results presented in an Akesis Pharmaceuticals media release.
- 04 Jun 2008 Status changed from recruiting to completed as reported by Akesis Pharmaceuticals.
- 17 Mar 2008 Results for 4 patients have been reported in an Akesis Pharmaceuticals media release (see 9086466).